Hence, we examined the expression of Brca1 because its deficiency triggers BL‐like and TNBC cancer formation.[21, 22] RT‐PCR revealed that the Brca1 mRNA levels were lower in mutant mammary glands and tumors than in the controls (Figure4A). The gene discussed is BRCA1; the disease is cancer.